Mack David Henry
SEC CIK 1341642 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals, Inc. | Pres, CEO, Dir | 451.1K | — | $1.06M | 16 | 2021-03-09 | 2025-10-27 |
Most active insiders at PMVP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OrbiMed Capital GP V LLC | 10% | — | $1.52M |
| 2 | Mack David Henry | Pres, CEO, Dir | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-29 | 2025-10-27 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $1.37 | +220.6K | 451.1K | +96% | +$302.3K |
| 2025-07-03 | 2025-07-01 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | S - Sale | $1.06 | -58.4K | 536.1K | -10% | -$61.9K | |
| DM | 2025-01-22 | 2024-12-03+ | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +109.5K | 551.9K | +25% | +$58.0K |
| D | 2024-01-22 | 2024-01-18 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | A - Grant | $0.00 | +163.9K | 442.5K | +59% | $0 |
| D | 2023-11-13 | 2023-11-10 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | -85.3K | 278.6K | -23% | $0 |
| D | 2023-11-13 | 2023-10-18 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +198.4K | 363.9K | +120% | +$105.2K |
| DI | 2023-11-13 | 2023-11-10 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | +85.3K | 165.3K | +107% | $0 |
| D | 2023-08-08 | 2023-08-07 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +85.5K | 165.5K | +107% | +$45.3K |
| D | 2022-04-29 | 2022-04-27 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +33.0K | 80.0K | +70% | +$17.5K |
| DMI | 2022-03-09 | 2021-03-09 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | 0 | 80.0K | New | $0 |
| D | 2022-03-09 | 2022-03-08 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $1.37 | +20.0K | 47.0K | +74% | +$27.4K |
| D | 2021-12-16 | 2021-12-15 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +9,000 | 27.0K | +50% | +$4,770 |
| DMI | 2021-12-16 | 2021-12-09 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | G - Gift | $0.00 | 0 | 187.9K | New | $0 |
| D | 2021-08-20 | 2021-08-19 | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +5,500 | 18.0K | +44% | +$2,915 |
| DM | 2021-07-22 | 2021-07-20+ | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | S - Sale+OE | $35.75 | -27.8K | 12.5K | -69% | -$993.7K |
| DM | 2021-07-22 | 2021-07-20+ | PMVP | PMV Pharmaceuticals, Inc. | Mack David Henry | Pres, CEO, Dir | M - OptEx | $0.53 | +27.8K | 13.5K | New | +$14.7K |
Purchase Sale Sale after option exercise All abbreviations